Quantcast

Latest Channelopathy Stories

2009-10-22 12:13:10

Electronic eye implanted at NewYork-Presbyterian Hospital/Columbia mimics human retina A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. A team led by Dr. Lucian V. Del Priore at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the June 26 surgery -- the first case of its kind in New York. The first treatment aimed at restoring...

2009-10-20 19:16:21

Retinal prosthesis and fetal tissue transplant show promise in human studies Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored...

2009-10-14 14:34:53

The most common gene for a syndrome associated with abnormal heart rhythms and sudden death triggers epileptic seizures and could explain sudden unexplained death in epilepsy, said researchers from Baylor College of Medicine in a report that appears today in the journal Science Translational Medicine. The identification of this particular potassium channel KvLQT in neurons of the central nervous system gives scientists a clue about which epilepsy patients face the greatest risk of dying...

2009-10-12 16:53:19

A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death. The investigators "“ from the United States, Italy and South Africa "“ report in the journal Circulation that variations in the gene NOS1AP increase the risk of cardiac symptoms and sudden death in patients who have an inherited cardiac disease called congenital long-QT syndrome. The findings will help in assessing the risk of sudden death "“ and...

2009-09-28 08:18:00

PARSIPPANY, N.J., Sept. 28 /PRNewswire/ -- JHP Pharmaceuticals, LLC ("JHP") announced today that it had developed, and received approval by the FDA for Dantrium® IV (dantrolene sodium for injection), a rapidly mixing product. Dantrium® IV now reconstitutes in approximately 20 seconds, which is 4 times faster than before, saving valuable time and effort during a malignant hyperthermia (MH) emergency. Dantrium® IV, the rapidly mixing...

2009-09-20 13:36:25

2 genes represent potential drug targets for both heart and endocrine disease Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers. The authors' findings, published online this week by the peer-reviewed journal Nature Medicine, suggest that mutations of either of two gene products...

2009-09-09 00:03:05

A South Jersey man says his eyesight is returning, weeks after doctors at Wills Eye Institute in Philadelphia implanted electrodes behind his left eye. Michael Adler, 49, began losing his sight as a child, The Philadelphia Inquirer reported Tuesday. Recently, when he was sitting in church he saw what he described as an odd white glow -- which turned out to be an open hymnal. Every day, I can make out more than I could the day before, he told the newspaper after tests at the University of...

2009-07-28 10:30:00

Seven applicants receive a total of over $1.7 million BERWYN, Pa., July 28 /PRNewswire-USNewswire/ -- The NephCure Foundation (NCF) has awarded more than $1.7 million to researchers in its 2009 Scientific Research Grant Program. The announcement was made by Henry Brehm, NephCure Foundation's Executive Director and Dr. Lawrence Holzman, Chair of the NCF Scientific Advisory Board. The Scientific Grant Program supports basic, transitional and clinical research initiatives to understand the...

2009-07-21 12:19:19

Using a common cold virus to deliver a corrected gene to cystic fibrosis cells restores normal function to lung tissue, researchers in North Carolina said. The treatment is the most efficient gene therapy for cystic fibrosis to be found in the last 20 years, researchers at the University of North Carolina said Tuesday in a release. The next step is to ensure the safety of the delivery system so it can be administered to cystic fibrosis patients, who suffer from thicker-than-normal mucus that...

2009-07-16 11:10:19

Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.The treatments not only help breathing in the short term - they may also make lung infections develop to be less harmful in the long run, research from the University of Edinburgh shows.Scientists studied how bacteria which infect the lungs of cystic fibrosis patients gather nutrients from their surroundings. The work builds on the knowledge that most bacteria...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related